Plain-English translation of NCT06584123 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer imaging scan called 18F-fluoroethyltyrosine PET (FET-PET) can give doctors the same helpful information as an older scan called 11C-methionine PET (Met-PET) for diagnosing and monitoring pituitary adenomas—tumors of the pituitary gland. Researchers want to see if the newer scan works just as well, which could make this type of advanced imaging available to more patients. You would have already had one scan as part of your regular care, and this study would add one additional scan for comparison.
Currently, the older imaging scan is the standard way to look closely at pituitary tumors, but it may not be available everywhere. If the newer scan produces similar results, doctors could offer more patients access to this detailed imaging to better diagnose and monitor their condition.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have one additional PET scan (FET-PET) performed at the hospital. The scan involves receiving an injection of a radioactive tracer, waiting for it to circulate in your body, then lying still in a scanner for 30 to 60 minutes while images are taken. Doctors will then compare the images from this new scan with the images from your previous Met-PET scan to see whether they show similar findings about your pituitary tumor.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United Kingdom
Sponsor
University of Cambridge
Collaborators
Cambridge University Hospitals NHS Foundation Trust
Enrollment target
~20 participants
Started
September 2024
Primary completion
September 2026
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
James MacFarlane
Cambridge University Hospitals NHS Foundation Trust
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.